Chelsea Therapeutics International Ltd. (Nasdaq: CHTP) will discuss questions today at the BIO CEO and Investor Conference that the Food and Drug Administration posed while reviewing its New Drug Application for NORTHERA. Shares of the pharmaceutical plunged $1.76 to $3.23.
Chelsea Therapeutics Will Discuss FDA Questions
February 13, 2012 at 13:31 PM EST
